Form 8-K - Current report:
SEC Accession No. 0001104659-20-062094
Filing Date
2020-05-15
Accepted
2020-05-15 08:00:30
Documents
28
Period of Report
2020-05-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2019577d1_8k.htm 8-K 20540
2 EXHIBIT 99.1 tm2019577d1_ex99-1.htm EX-99.1 9948
3 EXHIBIT 99.2 tm2019577d1_ex99-2.htm EX-99.2 4960
4 EXHIBIT 99.3 tm2019577d1_ex99-3.htm EX-99.3 3415
5 EXHIBIT 99.4 tm2019577d1_ex99-4.htm EX-99.4 4850
6 EXHIBIT 99.5 tm2019577d1_ex99-5.htm EX-99.5 3246
7 EXHIBIT 99.6 tm2019577d1_ex99-6.htm EX-99.6 11346
8 GRAPHIC ex99-2pg_001.jpg GRAPHIC 222977
9 GRAPHIC ex99-3pg_001.jpg GRAPHIC 114608
10 GRAPHIC ex99-3pg_002.jpg GRAPHIC 129677
11 GRAPHIC ex99-3pg_003.jpg GRAPHIC 163418
12 GRAPHIC ex99-4pg_001.jpg GRAPHIC 239607
13 GRAPHIC ex99-5pg_001.jpg GRAPHIC 128234
14 GRAPHIC ex99-5pg_002.jpg GRAPHIC 145063
15 GRAPHIC ex99-5pg_003.jpg GRAPHIC 164127
16 GRAPHIC ex99-6pg_001.jpg GRAPHIC 125757
17 GRAPHIC ex99-6pg_002.jpg GRAPHIC 113704
18 GRAPHIC ex99-6pg_003.jpg GRAPHIC 114176
19 GRAPHIC ex99-6pg_004.jpg GRAPHIC 123140
20 GRAPHIC ex99-6pg_005.jpg GRAPHIC 126474
21 GRAPHIC ex99-6pg_006.jpg GRAPHIC 101537
22 GRAPHIC ex99-6pg_007.jpg GRAPHIC 68149
23 GRAPHIC ex99-6pg_008.jpg GRAPHIC 97856
24 GRAPHIC ex99-6pg_009.jpg GRAPHIC 93363
25 GRAPHIC ex99-6pg_010.jpg GRAPHIC 74992
26 GRAPHIC ex99-6pg_011.jpg GRAPHIC 78660
27 GRAPHIC ex99-6pg_012.jpg GRAPHIC 116484
28 GRAPHIC logo.gif GRAPHIC 2678
  Complete submission text file 0001104659-20-062094.txt   3567287
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 20880651
SIC: 2834 Pharmaceutical Preparations